Akribion Therapeutics ("Akribion"), the early-stage biotech developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion, today announces its exit from stealth and the ...
Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...
Akribion Therapeutics ("Akribion"), the early-stage biotech developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion, today announces its exit from stealth and the ...
A study reveals DNA and RNA epigenetics work together as a complementary system for precise gene regulation, crucial for cell ...
Researchers have identified various distinctive immune cells in cow's milk, creating potential avenues for enhancing animal ...
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, ...
Northwestern Medicine scientists have uncovered a key pathway controlling tumor growth in B-cell lymphomas, according to a ...
Scientists rebuild the body's own proteins and fats into nano delivery vans that get genetic medicines to exactly the right ...
Hosted on MSN21h
Microscopy Technique Tracks Ribosome ActivityA novel microscopy method has been created by researchers from the Tanenbaum group at the Hubrecht Institute to view the ...
A large research team led by nanotechnologist Roy van der Meel rebuilt the body's own proteins and fats into nano-delivery ...
A large research team led by nanotechnologist Roy van der Meel rebuild the body's own proteins and fats into nano delivery ...
There are notable differences between men and women in their susceptibility to many human diseases, including cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback